CD2AP and hepatocellular carcinoma: More surprisingly, in vitro experiments showed that CD2AP was highly expressed in both HCC tissues and cells, and knockdown of CD2AP inhibited the capabilities of proliferation, migration, and invasion in Huh7 and HepG2 cells, which is consistent with the oncogenic role of CD2AP in other cancers [45,46].